Government urged to re-establish pharmacoeconomics program
Published: 2010-05-27 06:59:00
Updated: 2010-05-27 06:59:00
The government will have to re-evaluate the economic effectiveness of antihypertensive agents by clinicians who can induce a clinical rationale based on fair and transparent standpoint, the local two organizations said in a joint statement on May 24.
The Korea Pharmaceutical Manufacturers Asso...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
